CrisisCare

“An apparently young and healthy patient had a second case of Covid-19 infection which was diagnosed 4.5 months after the first episode,” University of Hong Kong researchers said Monday in a statement.

The report is of concern because it suggests that immunity to the coronavirus may last only a few months in some people. And it has implications for vaccines being developed for the virus.

Country / Region Tags:

China

General Topic Tags:

Problem, Solution, SitRep, or ?:

Problem

Situation Report

Read more about Work by researchers in Hong Kong founds that reinfection may be possible in rare cases.
Log in or register to post comments

WHO says plasma therapy still ‘experimental’ --plus other developments

Mon, 2020-08-24 09:29 — mike kraft

The Latest: WHO says plasma therapy still 'experimental' GENEVA — The World Health Organization says using plasma from the recovered to treat COVID-19 is still considered an “experimental” therapy and that the preliminary results showing it may work are... AP NEWS

GENEVA — The World Health Organization says using plasma from the recovered to treat COVID-19 is still considered an “experimental” therapy and that the preliminary results showing it may work are still “inconclusive.”

President Donald Trump on Sunday approved an emergency authorization of convalescent plasma for COVID-19 patients.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Problem

Read more about WHO says plasma therapy still ‘experimental’ --plus other developments
Log in or register to post comments

INVESTIGATION: Meatpacking Companies Reportedly Dismissed Years of Warnings but Now Say Nobody Could Have Prepared for COVID-19

Sun, 2020-08-23 18:55 — mike kraft

Meatpacking Companies Dismissed Years of Warnings but Now Say Nobody Could Have Prepared for COVID-19 In documents dating to 2006, government officials predicted that a pandemic would threaten critical businesses and warned them to prepare. Meatpacking companies largely ignored them, and now nearly… Michael Grabell,Bernice Yeung ProPublica

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Problem

NURSING HOME: Experimental drug used to stop COVID-19 spread

Sun, 2020-08-23 12:35 — mike kraft

The coronavirus crept into Heartland Health Care Center, a nursing home in Moline, Ill., on the last day of July, when a member of the nursing staff tested positive.

It was an ominous sign: The virus can spread through a nursing home in a flash. Older people — who are often sick and frail and need regular hands-on attention — are uniquely susceptible. Staff members who care for residents are at high risk of infection and of unintentionally spreading the virus.

Although nursing home residents make up just 1.2 percent of the United States population, they account for about 40 percent of Covid-19 deaths.

But this time, the nursing home was not defenseless. Heartland was the first facility to participate in a large clinical trial of a drug that might protect residents from the infection in nursing homes and assisted living facilities.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?: